시장조사 보고서 : 세계의 흑색종 피부암 진단 검사 시장예측 2021년-2026년

■ 영문 제목 : Global Melanoma Skin Cancer Diagnostic Testing Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K03867 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2026년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 서비스

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 흑색종 피부암 진단 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (생검, 화상, 기타)와 용도별 시장규모 (병원, 피부과 클리닉, 진단 연구소, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 흑색종 피부암 진단 검사 시장 점유율
- 지역별 흑색종 피부암 진단 검사 시장규모
- 주요지역의 종류별 시장규모 (생검, 화상, 기타)
- 주요지역의 용도별 시장규모 (병원, 피부과 클리닉, 진단 연구소, 기타)
- 미주의 흑색종 피부암 진단 검사 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 흑색종 피부암 진단 검사 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 흑색종 피부암 진단 검사 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 흑색종 피부암 진단 검사 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 흑색종 피부암 진단 검사 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech, Sysmex Inostics
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Melanoma Skin Cancer Diagnostic Testing will have significant change from previous year. By the most conservative estimates of global Melanoma Skin Cancer Diagnostic Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Melanoma Skin Cancer Diagnostic Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Melanoma Skin Cancer Diagnostic Testing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Biopsy
Imaging
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Dermatology Clinics
Diagnostic Laboratories
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Myriad Genetics
Abbott Laboratories
Foundation Medicine
Pathway Genomics Corporation
Cancer Genetics
Castle Biosciences
NeoGenomics
Dermtech
Sysmex Inostics

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size 2016-2026
2.1.2 Melanoma Skin Cancer Diagnostic Testing Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Melanoma Skin Cancer Diagnostic Testing Segment by Type
2.2.1 Biopsy
2.2.2 Biopsy
2.2.3 Others
2.3 Melanoma Skin Cancer Diagnostic Testing Market Size by Type
2.3.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size CAGR by Type
2.3.2 Global Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Type (2016-2021)
2.4 Melanoma Skin Cancer Diagnostic Testing Segment by Application
2.4.1 Hospitals
2.4.2 Dermatology Clinics
2.4.3 Diagnostic Laboratories
2.4.4 Others
2.5 Melanoma Skin Cancer Diagnostic Testing Market Size by Application
2.5.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size CAGR by Application
2.5.2 Global Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Application (2016-2021)

3 Melanoma Skin Cancer Diagnostic Testing Market Size by Players
3.1 Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Players
3.1.1 Global Melanoma Skin Cancer Diagnostic Testing Revenue by Players (2019-2021E)
3.1.2 Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Players (2019-2021E)
3.2 Global Melanoma Skin Cancer Diagnostic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Melanoma Skin Cancer Diagnostic Testing by Regions
4.1 Melanoma Skin Cancer Diagnostic Testing Market Size by Regions (2016-2021)
4.2 Americas Melanoma Skin Cancer Diagnostic Testing Market Size Growth (2016-2021)
4.3 APAC Melanoma Skin Cancer Diagnostic Testing Market Size Growth (2016-2021)
4.4 Europe Melanoma Skin Cancer Diagnostic Testing Market Size Growth (2016-2021)
4.5 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size Growth (2016-2021)

5 Americas
5.1 Americas Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2016-2021)
5.2 Americas Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2016-2021)
5.3 Americas Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2016-2021)
6.2 APAC Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2016-2021)
6.3 APAC Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Melanoma Skin Cancer Diagnostic Testing by Country (2016-2021)
7.2 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2016-2021)
7.3 Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing by Region (2016-2021)
8.2 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2016-2021)
8.3 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.1 Global Melanoma Skin Cancer Diagnostic Testing Forecast by Regions (2021-2026)
10.1.1 Global Melanoma Skin Cancer Diagnostic Testing Forecast by Regions (2021-2026)
10.1.2 Americas Melanoma Skin Cancer Diagnostic Testing Forecast
10.1.3 APAC Melanoma Skin Cancer Diagnostic Testing Forecast
10.1.4 Europe Melanoma Skin Cancer Diagnostic Testing Forecast
10.1.5 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Forecast
10.2 Americas Melanoma Skin Cancer Diagnostic Testing Forecast by Countries (2021-2026)
10.2.1 United States Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.2.2 Canada Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.2.3 Mexico Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.2.4 Brazil Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.3 APAC Melanoma Skin Cancer Diagnostic Testing Forecast by Region (2021-2026)
10.3.1 China Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.3.2 Japan Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.3.3 Korea Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.3.4 Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.3.5 India Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.3.6 Australia Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.4 Europe Melanoma Skin Cancer Diagnostic Testing Forecast by Country (2021-2026)
10.4.1 Germany Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.4.2 France Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.4.3 UK Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.4.4 Italy Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.4.5 Russia Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.5 Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Forecast by Region (2021-2026)
10.5.1 Egypt Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.5.2 South Africa Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.5.3 Israel Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.5.4 Turkey Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.5.5 GCC Countries Melanoma Skin Cancer Diagnostic Testing Market Forecast
10.6 Global Melanoma Skin Cancer Diagnostic Testing Forecast by Type (2021-2026)
10.7 Global Melanoma Skin Cancer Diagnostic Testing Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Information
11.1.2 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product Offered
11.1.3 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Myriad Genetics Main Business Overview
11.1.5 Myriad Genetics Latest Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product Offered
11.2.3 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Abbott Laboratories Main Business Overview
11.2.5 Abbott Laboratories Latest Developments
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Information
11.3.2 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product Offered
11.3.3 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Foundation Medicine Main Business Overview
11.3.5 Foundation Medicine Latest Developments
11.4 Pathway Genomics Corporation
11.4.1 Pathway Genomics Corporation Company Information
11.4.2 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product Offered
11.4.3 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Pathway Genomics Corporation Main Business Overview
11.4.5 Pathway Genomics Corporation Latest Developments
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Information
11.5.2 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product Offered
11.5.3 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Cancer Genetics Main Business Overview
11.5.5 Cancer Genetics Latest Developments
11.6 Castle Biosciences
11.6.1 Castle Biosciences Company Information
11.6.2 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product Offered
11.6.3 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Castle Biosciences Main Business Overview
11.6.5 Castle Biosciences Latest Developments
11.7 NeoGenomics
11.7.1 NeoGenomics Company Information
11.7.2 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product Offered
11.7.3 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 NeoGenomics Main Business Overview
11.7.5 NeoGenomics Latest Developments
11.8 Dermtech
11.8.1 Dermtech Company Information
11.8.2 Dermtech Melanoma Skin Cancer Diagnostic Testing Product Offered
11.8.3 Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Dermtech Main Business Overview
11.8.5 Dermtech Latest Developments
11.9 Sysmex Inostics
11.9.1 Sysmex Inostics Company Information
11.9.2 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product Offered
11.9.3 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Sysmex Inostics Main Business Overview
11.9.5 Sysmex Inostics Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Melanoma Skin Cancer Diagnostic Testing Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Biopsy
Table 3. Major Players of Imaging
Table 4. Major Players of Others
Table 5. Melanoma Skin Cancer Diagnostic Testing Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Type (2016-2021)
Table 8. Melanoma Skin Cancer Diagnostic Testing Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Application (2016-2021)
Table 11. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Players (2019-2021E)
Table 13. Melanoma Skin Cancer Diagnostic Testing Key Players Head office and Products Offered
Table 14. Melanoma Skin Cancer Diagnostic Testing Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Melanoma Skin Cancer Diagnostic Testing Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Regions 2016-2021
Table 19. Americas Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Country (2016-2021)
Table 21. Americas Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Type (2016-2021)
Table 23. Americas Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Application (2016-2021)
Table 25. APAC Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Region (2016-2021)
Table 27. APAC Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Type (2016-2021)
Table 29. APAC Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Application (2016-2021)
Table 31. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Country (2016-2021)
Table 33. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Type (2016-2021)
Table 35. Europe Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Melanoma Skin Cancer Diagnostic Testing
Table 44. Key Application and Potential Industries of Melanoma Skin Cancer Diagnostic Testing
Table 45. Key Challenges of Melanoma Skin Cancer Diagnostic Testing
Table 46. Key Trends of Melanoma Skin Cancer Diagnostic Testing
Table 47. Global Melanoma Skin Cancer Diagnostic Testing Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Melanoma Skin Cancer Diagnostic Testing Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Melanoma Skin Cancer Diagnostic Testing Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Melanoma Skin Cancer Diagnostic Testing Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Melanoma Skin Cancer Diagnostic Testing Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Melanoma Skin Cancer Diagnostic Testing Market Size Market Share Forecast by Application (2021-2026)
Table 53. Myriad Genetics Details, Company Type, Melanoma Skin Cancer Diagnostic Testing Area Served and Its Competitors
Table 54. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product Offered
Table 55. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Myriad Genetics Main Business
Table 57. Myriad Genetics Latest Developments
Table 58. Abbott Laboratories Details, Company Type, Melanoma Skin Cancer Diagnostic Testing Area Served and Its Competitors
Table 59. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product Offered
Table 60. Abbott Laboratories Main Business
Table 61. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Abbott Laboratories Latest Developments
Table 63. Foundation Medicine Details, Company Type, Melanoma Skin Cancer Diagnostic Testing Area Served and Its Competitors
Table 64. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product Offered
Table 65. Foundation Medicine Main Business
Table 66. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Foundation Medicine Latest Developments
Table 68. Pathway Genomics Corporation Details, Company Type, Melanoma Skin Cancer Diagnostic Testing Area Served and Its Competitors
Table 69. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product Offered
Table 70. Pathway Genomics Corporation Main Business
Table 71. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Pathway Genomics Corporation Latest Developments
Table 73. Cancer Genetics Details, Company Type, Melanoma Skin Cancer Diagnostic Testing Area Served and Its Competitors
Table 74. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product Offered
Table 75. Cancer Genetics Main Business
Table 76. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Cancer Genetics Latest Developments
Table 78. Castle Biosciences Details, Company Type, Melanoma Skin Cancer Diagnostic Testing Area Served and Its Competitors
Table 79. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product Offered
Table 80. Castle Biosciences Main Business
Table 81. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Castle Biosciences Latest Developments
Table 83. NeoGenomics Details, Company Type, Melanoma Skin Cancer Diagnostic Testing Area Served and Its Competitors
Table 84. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product Offered
Table 85. NeoGenomics Main Business
Table 86. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. NeoGenomics Latest Developments
Table 88. Dermtech Details, Company Type, Melanoma Skin Cancer Diagnostic Testing Area Served and Its Competitors
Table 89. Dermtech Melanoma Skin Cancer Diagnostic Testing Product Offered
Table 90. Dermtech Main Business
Table 91. Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Dermtech Latest Developments
Table 93. Sysmex Inostics Details, Company Type, Melanoma Skin Cancer Diagnostic Testing Area Served and Its Competitors
Table 94. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product Offered
Table 95. Sysmex Inostics Main Business
Table 96. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Sysmex Inostics Latest Developments
List of Figures
Figure 1. Melanoma Skin Cancer Diagnostic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Melanoma Skin Cancer Diagnostic Testing Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Type in 2020
Figure 7. Melanoma Skin Cancer Diagnostic Testing in Hospitals
Figure 8. Global Melanoma Skin Cancer Diagnostic Testing Market: Hospitals (2016-2021) & ($ Millions)
Figure 9. Melanoma Skin Cancer Diagnostic Testing in Dermatology Clinics
Figure 10. Global Melanoma Skin Cancer Diagnostic Testing Market: Dermatology Clinics (2016-2021) & ($ Millions)
Figure 11. Melanoma Skin Cancer Diagnostic Testing in Diagnostic Laboratories
Figure 12. Global Melanoma Skin Cancer Diagnostic Testing Market: Diagnostic Laboratories (2016-2021) & ($ Millions)
Figure 13. Melanoma Skin Cancer Diagnostic Testing in Others
Figure 14. Global Melanoma Skin Cancer Diagnostic Testing Market: Others (2016-2021) & ($ Millions)
Figure 15. Global Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Application in 2020
Figure 16. Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share by Player in 2020
Figure 17. Global Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Regions (2016-2021)
Figure 18. Americas Melanoma Skin Cancer Diagnostic Testing Market Size 2016-2021 ($ Millions)
Figure 19. APAC Melanoma Skin Cancer Diagnostic Testing Market Size 2016-2021 ($ Millions)
Figure 20. Europe Melanoma Skin Cancer Diagnostic Testing Market Size 2016-2021 ($ Millions)
Figure 21. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size 2016-2021 ($ Millions)
Figure 22. Americas Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Country in 2020
Figure 23. Americas Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Type in 2020
Figure 24. Americas Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Application in 2020
Figure 25. United States Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 26. Canada Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 27. Mexico Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 28. APAC Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Regions in 2020
Figure 29. APAC Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Type in 2020
Figure 30. APAC Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Application in 2020
Figure 31. China Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 32. Japan Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 33. Korea Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 34. Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 35. India Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 36. Australia Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 37. Europe Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Country in 2020
Figure 38. Europe Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Type in 2020
Figure 39. Europe Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Application in 2020
Figure 40. Germany Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 41. France Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 42. UK Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 43. Italy Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 44. Russia Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 45. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Region in 2020
Figure 46. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Type in 2020
Figure 47. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size Market Share by Application in 2020
Figure 48. Egypt Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 49. South Africa Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 50. Israel Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 51. Turkey Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 52. GCC Country Melanoma Skin Cancer Diagnostic Testing Market Size Growth 2016-2021 ($ Millions)
Figure 53. Americas Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 54. APAC Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 55. Europe Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 56. Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 57. United States Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 58. Canada Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 59. Mexico Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 60. Brazil Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 61. China Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 62. Japan Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 63. Korea Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 64. Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 65. India Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 66. Australia Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 67. Germany Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 68. France Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 69. UK Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 70. Italy Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 71. Russia Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 72. Spain Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 73. Egypt Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 74. South Africa Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 75. Israel Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 76. Turkey Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)
Figure 77. GCC Country Melanoma Skin Cancer Diagnostic Testing Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 흑색종 피부암 진단 검사 시장예측 2021년-2026년] (코드 : LPI-2201K03867) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 흑색종 피부암 진단 검사 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 전이성 흑색종 진단 시장예측 2021년-2026년
LPI-2201K03870 / LP Information / 2021년 12월 / 본 조사보고서는 전이성 흑색종 진단의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Metastatic Melanoma Diagnostic will have significant change from previous year. By the most conservative estimates of global Metastatic Melanoma Diagnostic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 췌장암 진단 시장예측 2021년-2026년
LPI-2201K02257 / LP Information / 2021년 12월 / 본 조사보고서는 췌장암 진단의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pancreatic Cancer Diagnostic will have significant change from previous year. By the most conservative estimates of global Pancreatic Cancer Diagnostic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 5143.6 million in...

세계의 유전성 암 검사 시장예측 2021년-2026년
LPI-2201K00125 / LP Information / 2021년 12월 / 본 조사보고서는 유전성 암 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Hereditary Cancer Testing will have significant change from previous year. By the most conservative estimates of global Hereditary Cancer Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 전립선암 진단 시장예측 2021년-2026년
LPI-2201K02283 / LP Information / 2021년 12월 / 본 조사보고서는 전립선암 진단의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Prostate Cancer Diagnostics will have significant change from previous year. By the most conservative estimates of global Prostate Cancer Diagnostics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 12250 million in...

세계의 체외 암 진단 시약 키트 시장예측 2021년-2026년
LPI-2201K00305 / LP Information / 2021년 12월 / 본 조사보고서는 체외 암 진단 시약 키트의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of In-Vitro Cancer Diagnostic Reagent Kit will have significant change from previous year. By the most conservative estimates of global In-Vitro Cancer Diagnostic Reagent Kit market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 HPV 검사 시장예측 2021년-2026년
LPI-2201K00134 / LP Information / 2021년 12월 / 본 조사보고서는 HPV 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of HPV Testing will have significant change from previous year. By the most conservative estimates of global HPV Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 724.9 million in 2020. Over...

세계의 잠재성 결핵감염증 (LTBI) 검사 시장예측 2021년-2026년
LPI-2201K00166 / LP Information / 2021년 12월 / 본 조사보고서는 잠재성 결핵감염증 (LTBI) 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Latent Tuberculosis Infection (LTBI) Testing will have significant change from previous year. By the most conservative estimates of global Latent Tuberculosis Infection (LTBI) Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 체외 진단 (IVD) 용 시약 시장예측 2021년-2026년
LPI-2201K00065 / LP Information / 2021년 12월 / 본 조사보고서는 체외 진단 (IVD) 용 시약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of In Vitro Diagnostic (IVD) Reagents will have significant change from previous year. By the most conservative estimates of global In Vitro Diagnostic (IVD) Reagents market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...